BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17682341)

  • 1. Proteomics in cancer.
    Reymond MA; Schlegel W
    Adv Clin Chem; 2007; 44():103-42. PubMed ID: 17682341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics to diagnose human tumors and provide prognostic information.
    Ornstein DK; Petricoin EF
    Oncology (Williston Park); 2004 Apr; 18(4):521-9; discussion 529-32. PubMed ID: 15134357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.
    Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L
    Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer proteomics: a review for clinicians.
    Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELDI-TOF proteomic analysis and cancer detection.
    Henderson NA; Steele RJ
    Surgeon; 2005 Dec; 3(6):383-90, 422. PubMed ID: 16353858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of cancer of hormone-dependent tissues.
    Tyson DR; Ornstein DK
    Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
    Seibert V; Ebert MP; Buschmann T
    Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics for cancer biomarker discovery.
    Liang S; Xu Z; Xu X; Zhao X; Huang C; Wei Y
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):221-31. PubMed ID: 22221055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI mass spectrometry in prostate cancer biomarker discovery.
    Flatley B; Malone P; Cramer R
    Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
    Gonçalves A; Bertucci F; Birnbaum D; Borg JP
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry in diagnostic oncoproteomics.
    Roboz J
    Cancer Invest; 2005; 23(5):465-78. PubMed ID: 16193645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic strategies for the characterization and the early detection of lung cancer.
    Massion PP; Caprioli RM
    J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of advanced proteomics technologies to cancer diagnosis.
    Ciordia S; de Los Ríos V; Albar JP
    Clin Transl Oncol; 2006 Aug; 8(8):566-80. PubMed ID: 16952845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to proteomic analysis of breast cancer.
    Wulfkuhle JD; McLean KC; Paweletz CP; Sgroi DC; Trock BJ; Steeg PS; Petricoin EF
    Proteomics; 2001 Oct; 1(10):1205-15. PubMed ID: 11721633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteomic analysis of protein profiles in some pathological stages of the human organism].
    Kossowska B; Dudka I; Gancarz R; Antonowicz-Juchniewicz J
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():549-63. PubMed ID: 19940332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.